Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-06

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (CIPLA USA INC.,)

View source ↗

Summary

FDA approved a supplemental application for bupropion hydrochloride from CIPLA USA INC., under the generic drug approval pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)